Update in ARDS management: Recent randomized controlled trials that changed our practice

Cleveland Clinic Journal of Medicine

Volumn 73, Issue 3, 2006, Pages 217-236

  Santacruz, J Fernando ^a   Diaz Guzman Zavala, Enrique ^a   Arroliga, Alejandro C ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOCONAZOLE; LUNG SURFACTANT; NEUROMUSCULAR BLOCKING AGENT; NITRIC OXIDE; OXYGEN; PERFLUOROOCTYL BROMIDE; PLACEBO; PROTEIN C; RECOMBINANT PROTEIN; SEDATIVE AGENT; SIVELESTAT; DRUG DERIVATIVE; GLYCINE; SERINE PROTEINASE INHIBITOR; SULFONAMIDE;

ACUTE LUNG INJURY; ARTIFICIAL VENTILATION; BODY POSTURE; BODY WEIGHT; CLINICAL PRACTICE; CLINICAL TRIAL; HIGH FREQUENCY OSCILLATION; HIGH FREQUENCY VENTILATION; HUMAN; LOW DRUG DOSE; MORTALITY; OXYGENATION; PATIENT SAFETY; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; RESPIRATORY DISTRESS; REVIEW; SURVIVAL; TIDAL VOLUME; TREATMENT OUTCOME; ADULT RESPIRATORY DISTRESS SYNDROME; CONTROLLED CLINICAL TRIAL; LIQUID VENTILATION; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; UNITED STATES;

GLYCINE; HIGH-FREQUENCY VENTILATION; HUMANS; LIQUID VENTILATION; NITRIC OXIDE; OHIO; POSITIVE-PRESSURE RESPIRATION; PRONE POSITION; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY DISTRESS SYNDROME, ADULT; SERINE PROTEINASE INHIBITORS; SULFONAMIDES; SURVIVAL RATE; TIDAL VOLUME;

EID: 33645500596     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.73.3.217     Document Type: Review

References (21)

1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349.
2. Frutos-Vivar F, Nin N, Esteban A. Epidemiology of acute lung injury and acute respiratory distress syndrome. Curr Opin Crit Care 2004, 10:1-6.
3. Esteban A, Anzueto A, Frutos F, et al; Mechanical Ventilation International Study Group. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 2002; 287:345-355.
4. Marini JJ. Evolving concepts in the ventilatory management of acute respiratory distress syndrome. Clin Chest Med 1996; 17:555-575.
5. Slutsky AS, Tremblay LN. Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 1998, 157:1721-1725.
6. Parsons PE, Eisner MD, Thompson BT et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33:1-6.
7. Stewart TE, Meade MO, Cook DJ, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med 1998; 338:355-361.
8. Brochard L, Roudot-Thoraval F, Roupie E, et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 158:1831-1838.
9. Brower RG, Shanholtz CB, Fessler HE, et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999; 27:1492-1498.
10. Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347-354.
11. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308.
12. Brower RG, Lanken PN, MacIntyre N, et al; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351:327-336.
13. Gattinoni L, Tognoni G, Pesenti A, et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001; 345:568-573.
14. Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 2004; 292:2379-2387.
15. Derdak S, Mehta S, Stewart TE, et al, Multicenter Oscillatory Ventilation for Acute Respiratory Distress Syndrome Trial (MOAT) Study investigators. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults. A randomized, controlled trial. Am J Respir Crit Care Med 2002; 166:801-808.
16. Spragg RG, Lewis JF, Walmrath HD, et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004; 351:884-892.
17. Taylor RW, Zimmerman JL, Dellinger RP, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004; 291:1603-1609.
18. Hirschl RB, Croce M, Gore D, et al; The Adult Partial Liquid Ventilation Study Group. Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am J Respir Crit Care Med 2002; 165:781-787.
19. Kacmarek RM, Wiedemann HP, Lavin PT, Wedel MK, Tutuncu AS, Slutsky AS. Partial liquid ventilation in adult patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2005 Oct 27; published ahead of print.
20. The ARDS Network. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2000; 283:1995-2002.
21. Zeiher BG, Artigas A, Vincent JL, et al; STRIVE Study Group. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 2004; 32:1695-1702.